BIOCAD, a biopharma company from outside Moscow, has developed and presented recently in Europe its Algeron, an innovation drug to fight C-type hepatitis.Algeron is expected to be marketed not only in Russia but in many other countries. The new drug is ...
[Published Marchmont.ru - May 28 2013]